Children of the wealthy and connected get special admissions consideration at some elite U.S. universities, according to new filings in a class-action lawsuit originally brought against 17 schools. Georgetown’s then-president, for example, listed a prospective student on his “president’s list” after meeting her and her wealthy father at an Idaho conference known as “summer camp for billionaires,” according to Tuesday court filings in the price-fixing lawsuit filed in Chicago federal court in 2022. Although it’s always been assumed that such favoritism exists, the filings offer a rare peek at the often secret deliberations of university heads and admissions officials. They show how schools admit otherwise unqualified wealthy children because their parents have connections and could possibly donate large sums down the line, raising questions about fairness. Stuart Schmill, the dean of admissions at the Massachusetts Institute of Technology, wrote in a 2018 email that the university admitted four out of six applicants recommended by then-board chairman Robert Millard, including two who “we would really not have otherwise admitted.” The two others were not admitted because they were “not in the ball park, or the push from him was not as strong.” In the email, Schmill said Millard was careful to play down his influence on admissions decisions, but he said the chair also sent notes on all six students and later met with Schmill to share insight “into who he thought was more of a priority.” The filings are the latest salvo in a lawsuit that claims that 17 of the nation’s most prestigious colleges colluded to reduce the competition for prospective students and drive down the amount of financial aid they would offer, all while giving special preference to the children of wealthy donors. “That illegal collusion resulted in the defendants providing far less aid to students than would have been provided in a free market,” said Robert Gilbert, an attorney for the plaintiffs. Since the lawsuit was filed, 10 of the schools have reached settlements to pay out a total of $284 million, including payments of up to $2,000 to current or former students whose financial aid might have been shortchanged over a period of more than two decades. They are Brown, the University of Chicago, Columbia, Dartmouth, Duke, Emory, Northwestern, Rice, Vanderbilt and Yale. Johns Hopkins is working on a settlement and the six schools still fighting the lawsuit are the California Institute of Technology, Cornell, Georgetown, MIT, Notre Dame and the University of Pennsylvania. MIT called the lawsuit and the claims about admissions favoritism baseless. “MIT has no history of wealth favoritism in its admissions; quite the opposite,” university spokesperson Kimberly Allen said. “After years of discovery in which millions of documents were produced that provide an overwhelming record of independence in our admissions process, plaintiffs could cite just a single instance in which the recommendation of a board member helped sway the decisions for two undergraduate applicants." In a statement, Penn also said the case is meritless that the evidence shows that it doesn't favor students whose families have donated or pledged money to the Ivy League school. “Plaintiffs’ whole case is an attempt to embarrass the University about its purported admission practices on issues totally unrelated to this case," the school said. Notre Dame officials also called the case baseless. “We are confident that every student admitted to Notre Dame is fully qualified and ready to succeed,” a university spokesperson said in a statement. The South Bend, Indiana, school, though, did apparently admit wealthy students with subpar academic backgrounds. According to the new court filings, Don Bishop, who was then associate vice president for enrollment at Notre Dame, bluntly wrote about the “special interest” admits in a 2012 email, saying that year's crop had poorer academic records than the previous year's. The 2012 group included 38 applicants who were given a “very low” academic rating, Bishop wrote. He said those students represented “massive allowances to the power of the family connections and funding history,” adding that “we allowed their high gifting or potential gifting to influence our choices more this year than last year.” The final line of his email: “Sure hope the wealthy next year raise a few more smart kids!” Some of the examples pointed to in this week's court filings showed that just being able to pay full tuition would give students an advantage. During a deposition, a former Vanderbilt admissions director said that in some cases, a student would get an edge on the waitlist if they didn’t need financial aid. The 17 schools were part of a decades-old group that got permission from Congress to come up with a shared approach to awarding financial aid. Such an arrangement might otherwise violate antitrust laws, but Congress allowed it as long as the colleges all had need-blind admissions policies, meaning they wouldn't consider a student’s financial situation when deciding who gets in. The lawsuit argues that many colleges claimed to be need-blind but routinely favored the children of alumni and donors. In doing so, the suit says, the colleges violated the Congressional exemption and tainted the entire organization. The group dissolved in recent years when the provision allowing the collaboration expired. The Associated Press’ education coverage receives financial support from multiple private foundations. AP is solely responsible for all content. Find AP’s standards for working with philanthropies, a list of supporters and funded coverage areas at AP.org .
None
SEOUL, South Korea (AP) — South Korea's embattled President Yoon Suk Yeol avoided an opposition-led attempt to impeach him over his short-lived imposition of martial law , as most ruling party lawmakers boycotted a parliamentary vote Saturday to deny a two-thirds majority needed to suspend his presidential powers. The scrapping of the motion is expected to intensify public protests calling for Yoon’s ouster and deepen political chaos in South Korea, with a survey suggesting a majority of South Koreans support the president’s impeachment. Yoon’s martial law declaration drew criticism from his own ruling conservative People Power Party, but it is also determined to oppose Yoon’s impeachment apparently because it fears losing the presidency to liberals. After the motion fell through, members of the main liberal opposition Democratic Party rallied inside the National Assembly, chanting slogans calling for Yoon's impeachment or resignation. The party's floor leader, Park Chan-dae, said it will soon prepare for a new impeachment motion. “We'll surely impeach Yoon Suk Yeol, who is the greatest risk to Republic of Korea,” party leader Lee Jae-myung said. “We'll surely bring back this country to normal before Christmas Day or year's end.” Despite escaping the impeachment attempt, many experts worry Yoon won’t be able to serve out his remaining 2 1/2 years in office. They say some ruling party lawmakers could eventually join opposition parties’ efforts to impeach Yoon if public demands for it grow further. Protests against Yoon are swelling On Saturday, tens of thousands of people densely packed several blocks of roads leading up to the National Assembly, waving banners, shouting slogans and dancing. Protesters also gathered in front of PPP’s headquarters near the Assembly, angrily shouting for its lawmakers to vote to impeach Yoon. A smaller crowd of Yoon’s supporters, which still seemed to be in the thousands, rallied in separate streets in Seoul, decrying the impeachment attempt they saw as unconstitutional. Impeaching Yoon required support from two-thirds of the National Assembly, or 200 of its 300 members. The Democratic Party and five other small opposition parties, which filed the motion, have 192 seats combined. But only three lawmakers from PPP participated in the vote. The motion was scrapped without ballot counting because the number of votes didn’t reach 200. National Assembly Speaker Woo Won Shik called the result “very regrettable” and an embarrassing moment for the country’s democracy that has been closely watched by the world. “The failure to hold a qualified vote on this matter means we were not even able to exercise the democratic procedure of deciding on a critical national issue,” he said. Opposition parties could submit a new impeachment motion after a new parliamentary session opens next Wednesday. If Yoon is impeached, his powers will be suspended until the Constitutional Court decides whether to remove him from office. If he is removed, an election to replace him must take place within 60 days. Yoon apologizes for turmoil Earlier Saturday, Yoon issued a public apology over the martial law decree, saying he won’t shirk legal or political responsibility for the declaration and promising not to make another attempt to impose martial law. He said would leave it to his party to chart a course through the country’s political turmoil, “including matters related to my term in office.” “The declaration of this martial law was made out of my desperation. But in the course of its implementation, it caused anxiety and inconveniences to the public. I feel very sorry over that and truly apologize to the people who must have been shocked a lot,” Yoon said. Since taking office in 2022, Yoon has struggled to push his agenda through an opposition-controlled parliament and grappled with low approval ratings amid scandals involving himself and his wife. In his martial law announcement on Tuesday night, Yoon called parliament a “den of criminals” bogging down state affairs and vowed to eliminate “shameless North Korea followers and anti-state forces.” The turmoil resulting from Yoon’s bizarre and poorly-thought-out stunt has paralyzed South Korean politics and sparked alarm among key diplomatic partners like the U.S. and Japan. Tuesday night saw special forces troops encircling the parliament building and army helicopters hovering over it, but the military withdrew after the National Assembly unanimously voted to overturn the decree, forcing Yoon to lift it before daybreak Wednesday. The declaration of martial law was the first of its kind in more than 40 years in South Korea. Eighteen lawmakers from the ruling party voted to reject Yoon’s martial law decree along with opposition lawmakers. PPP later decided to oppose Yoon's impeachment motion. Yoon’s speech fueled speculation that he and his party may push for a constitutional amendment to shorten his term, instead of accepting impeachment, as a way to ease public anger over the marital law and facilitate Yoon’s early exit from office. Lee told reporters that Yoon’s speech was “greatly disappointing” and that the only way forward is his immediate resignation or impeachment. His party called Yoon’s martial law “unconstitutional, illegal rebellion or coup.” Lawmakers on Saturday first voted on a bill appointing a special prosecutor to investigate stock price manipulation allegations surrounding Yoon’s wife. Some lawmakers from Yoon’s party were seen leaving the hall after that vote, triggering angry shouts from opposition lawmakers. Yoon accused of ordering arrests of politicians On Friday, PPP chair Han Dong-hun, who criticized Yoon’s martial law declaration, said he had received intelligence that during the brief period of martial law Yoon ordered the country’s defense counterintelligence commander to arrest and detain unspecified key politicians based on accusations of “anti-state activities.” Hong Jang-won, first deputy director of South Korea’s National Intelligence Service, told lawmakers in a closed-door briefing Friday that Yoon had ordered him to help the defense counterintelligence unit to detain key politicians. The targeted politicians included Han, Lee and Woo, according to Kim Byung-kee, one of the lawmakers who attended the meeting. The Defense Ministry said Friday it suspended three military commanders including the head of the defense counterintelligence unit over their involvement in enforcing martial law. Vice Defense Minister Kim Seon Ho has told parliament that Defense Minister Kim Yong Hyun ordered the deployment of troops to the National Assembly after Yoon imposed martial law. Opposition parties accused Kim of recommending to Yoon to enforce martial law. Kim resigned Thursday, and prosecutors imposed an overseas travel ban on him. Kim Tong-hyung And Hyung-jin Kim, The Associated Press
Nvidia almost produced an x86 CPU to rival AMD and Intel, but was forced to move to Arm due to 'certain legal issues'How about a gift that pays you back?After Juan Soto's megadeal, could MLB see a $1 billion contract? Probably not soon
From Humza Yousaf’s demise to Donald Trump’s return, 2024 was an unpredictable rollercoaster in politics
For the second straight Major League Baseball offseason, a norm-shattering contract has been the talk of the winter, with Juan Soto agreeing with the New York Mets on a $765 million, 15-year deal that's the richest in baseball history. It comes almost exactly one year after the Los Angeles Dodgers forked out a princely sum of $700 million on a 10-year, heavily deferred deal for two-way Japanese superstar Shohei Ohtani. They are believed to be the two richest contracts in pro sports history. The way it's going, a contract approaching $1 billion doesn't seem out of the question. But several factors are working against it — at least in the near future. There's reason to believe the megadeals for Ohtani and Soto are unicorns in the baseball world. Both players are uniquely talented, surely, but both also had unusual circumstances propelling their value into the stratosphere. Ohtani is the greatest two-way player in baseball history, capable of improving any team on both sides of the ball. He's also the rare baseball player who has true international appeal. His every move ( like his unexpected marriage announcement ) is followed closely in his native Japan, adding another 125 million potential fans who buy merchandise, watch him play and help fill the Dodgers' coffers. Then there's Soto — a four-time All-Star and on-base machine who won a World Series with the Washington Nationals in 2019. The X-factor for him is he became a free agent at the prime age of 26, which is extremely hard to do under current MLB rules. Players have to be in the big leagues for six years before testing free agency. The precocious Soto debuted at 19 with the Nats, making him part of a rare group of players who reached the highest level of professional baseball as a teenager. That accelerated his free agency timeline. It's rare for players to debut that young, and rarer still for them to develop into stars and test the open market the first chance they get. Two recent examples are Manny Machado and Bryce Harper, who both reached free agency in 2019. Machado signed a free-agent record $300 million contract with San Diego, and Harper overtook him days later with a $330 million contract to join the Phillies. Most players debut in the big leagues from ages 22 to 26, which means free agency comes in their late 20s or early 30s. A typical example is Yankees slugger Aaron Judge, who is one of this generation's great players but didn't hit the market until he was 30. Judge played three seasons of college baseball for Fresno State before getting drafted by the Yankees in 2013 at age 21 — already two years older than Soto was when he made his MLB debut. It took a few years for the budding superstar to reach the majors, and he was 25 when he had his breakout season in 2018, smashing 52 homers to earn AL Rookie of the Year honors. By the time he reached free agency after the 2022 season, he had already passed age 30. It's a major factor that led to him signing a $360 million, nine-year deal with the Yankees, which seems downright reasonable these days after the Ohtani and Soto deals. Two major trends are colliding that will make it harder for guys like Soto to hit free agency in their mid 20s. First, MLB teams have been more likely in recent years to take college players early in the draft, betting on more experienced talents. Just 10 high school players were drafted among the top 30 picks in the 2024 draft. Second, teams are more eager to lock up young, premium talent on long-term deals very early in their careers, well before they hit free agency. Sometimes before they even reach the majors. Since Soto, just two players have debuted in MLB before their 20th birthday — Elvis Luciano and Junior Caminero. Luciano hasn't been back to the majors since his 2019 cup of coffee. Caminero is now 21 and has only played in 50 big league games. Among those that debuted at 20: Fernando Tatis Jr. signed a $340 million, 14-year deal with San Diego in 2021, years before reaching the open market. Milwaukee's Jackson Chourio got an $82 million, eight-year deal before even reaching the big leagues. Young stars Corbin Carroll ($111 million, eight years with Arizona), Bobby Witt Jr. ($288 million, 11 years with Kansas City) and Julio Rodriguez ($209.3 million, 12 years with Seattle) also got massive guarantees early in their 20s to forgo an early free agency. The exception and wild card: Blue Jays slugger Vladimir Guerrero Jr. will be a 26-year-old free agent next offseason. Guerrero hasn't been as consistent in his young career as Soto, but a standout 2025 season could position him to threaten Soto's deal. More likely is that the player to pass Soto isn't in the majors yet — and might not even be in pro baseball. When 25-year-old Alex Rodriguez signed his record $252 million, 10-year deal with Texas in 2001, it took over a decade for another player to match that total, when Albert Pujols got $240 million over 10 years from the Angels in 2012. For many players, passing up life-changing money in their early or mid 20s is too enticing, even if it means that they might not maximize their value on the free agent market later in their careers. Soto was determined to test the market. He famously turned down a $440 million, 15-year offer to stay with the Washington Nationals in 2022, betting that he could make even more as a free agent. Not many players would turn down that kind of cash. Then again, that's what makes Soto so unique. And it's also why his $765 million deal could be the industry standard for some time.Cancer – (21st June to 22nd July) Daily Horoscope Prediction says, Avoid arguments within the relationship Look for pleasant moments in the love affair and ensure you keep the professional cards ready for a game. You may expect financial troubles in the life today. Be ready to propose or to receive a proposal today. Utilize the opportunities at work to give the best results. There will be financial issues and you need to be careful while making crucial decisions. Health also requires extra attention. Cancer Love Horoscope Today Have a great love life where you both will engage in exciting activities. Consider your lover’s preferences while making decisions and this can seriously have positive results. Some love affairs that were on the brink of break up will also get a new lease of life. Ensure you give personal freedom to the partner and this will strengthen the relationship. Marriage is on the cards and you may also introduce the lover to the seniors at home for approval. Cancer Career Horoscope Today Consider new responsibilities at work that will test your mettle. Do not be a victim to office politics and also ensure you present innovative ideas at team meetings today. Your rapport with managers and human resources persons should be cordial. IT professionals, as well as copywriters, may need to spend long hours after the office at the workstation. Businessmen may consider expanding the market to new territories. Some traders will develop minor licensing issues and this needs immediate settlement. Cancer Money Horoscope Today Be careful about your financial status today. The returns from the previous investments will not be positive and this also adds pressure on your planning for investing in real estate and speculative business. Do not get into financial disputes with siblings or friends as things may get complicated. Some females will require spending for a celebration at the workplace. Today is not good to even invest in the stock market. Cancer Health Horoscope Today Minor health issues will be there but the routine life will go unhindered. Those who are suffering from hypertension may also need to be extra careful. Avoid Junk food and the sedentary lifestyle today. Yoga and meditation in the early morning will help you mentally healthy throughout the day. While going on adventure trips, ensure that you have a medical kit ready. Cancer Sign Attributes Strength: Intuitive, Practical, Kind, Energetic, Artsy, Dedicated, Benevolent, Caring Weakness: Insatiable, Possessive, Prudish Symbol: Crab Element: Water Body Part: Stomach & Breast Sign Ruler: Moon Lucky Day: Monday Lucky Color: White Lucky Number: 2 Lucky Stone: Pearl Cancer Sign Compatibility Chart Natural affinity: Taurus, Virgo, Scorpio, Pisces Good compatibility: Cancer, Capricorn Fair compatibility: Gemini, Leo, Sagittarius, Aquarius Less compatibility: Aries, Libra By: Dr. J. N. Pandey Vedic Astrology & Vastu Expert Website: www.astrologerjnpandey.com E-mail: djnpandey@gmail.com Phone: 91-9811107060 (WhatsApp Only)
Olivier Le Moal Author's Note: This is our monthly series on Dividend Stocks, usually published in the first week of every month. We scan the universe of roughly 7,500 stocks listed and traded on U.S. exchanges and use our proprietary filtering criteria to High Income DIY Portfolios: The primary goal of "High Income DIY Portfolios" Marketplace service is high income with low risk and preservation of capital. It provides DIY investors with vital information and portfolio/asset allocation strategies to help create stable, long-term passive income with sustainable yields. The portfolios are designed for Income-Investors (including retirees or near-retirees). We provide seven portfolios: 3 buy-and-hold, 3 Rotational portfolios, and 3-Bucket NPP Model Portfolio. This includes two High-Income portfolios, two DGI portfolios, and a conservative NPP strategy portfolio with low drawdowns and high growth. For more details or a two-week free trial, please click here . Financially Free Investor is a financial writer with 25 years investment experience. He focuses on investing in dividend-growing stocks with a long-term horizon. He applies a unique 3-basket investment approach that aims for 30% lower drawdowns, 6% current income, and market-beating growth on a long-term basis and he focuses on dividend-growing stocks with a long-term horizon. High Income DIY Portfolios Learn more Analyst’s Disclosure: I/we have a beneficial long position in the shares of ABT, ABBV, CI, JNJ, PFE, NVS, NVO, AZN, UNH, CL, CLX, UL, NSRGY, PG, TSN, ADM, BTI, MO, PM, KO, PEP, EXC, D, DEA, DEO, ENB, MCD, BAC, PRU, UPS, WMT, WBA, CVS, LOW, AAPL, IBM, CSCO, MSFT, INTC, T, VZ, CVX, XOM, VLO, ABB, ITW, MMM, LMT, LYB, RIO, O, NNN, WPC, ARCC, ARDC, AWF, BST, CHI, DNP, USA, UTF, UTG, RFI, RNP, RQI, EVT, EOS, FFC, GOF, HQH, HTA, IFN, HYB, TLT either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Disclaimer: The information presented in this article is for informational purposes only and in no way should be construed as financial advice or recommendation to buy or sell any stock. The author is not a financial advisor. Please always do further research and do your own due diligence before making any investments. Every effort has been made to present the data/information accurately; however, the author does not claim 100% accuracy. The stock portfolios presented here are model portfolios for demonstration purposes. For the complete list of our LONG positions, please see our profile on Seeking Alpha. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.Which stocks are taking off PSX to new heights?
STOCK MARKET SNAPSHOT FOR 19/12/2024Ministers told ‘incompetence’ at Met Office led to underestimation of Storm Bert
UC-MSCs is under clinical development by Wuhan Hamilton Bio-technology and currently in Phase I for Osteoarthritis. According to GlobalData, Phase I drugs for Osteoarthritis have an 84% phase transition success rate (PTSR) indication benchmark for progressing into Phase II. GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval. UC-MSCs overview The therapeutic candidate is under development for the treatment of knee osteoarthritis. The therapeutic candidate comprises of umbilical cord (UC)-derived mesenchymal stem cells (MSCs). It is administered by intravenous and intra-articular route. The therapeutic candidate was also under development for the treatment of diabetic nephropathy and pneumonia caused by coronavirus disease 2019 (COVID-19). For a complete picture of UC-MSCs’s drug-specific PTSR and LoA scores, This content was updated on 12 April 2024 From Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors. , the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. GlobalData’s Likelihood of Approval analytics tool dynamically assesses and predicts how likely a drug will move to the next stage in clinical development (PTSR), as well as how likely the drug will be approved (LoA). This is based on a combination of machine learning and a proprietary algorithm to process data points from various databases found on GlobalData’s .